Targeted Liposomal Drug Delivery in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2981-2989
Author(s):
Oula Penate Medina, Ying Zhu and Kalevi Kairemo
Peptide-Mediated Delivery of Therapeutic and Imaging Agents Into Mammalian Cells
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3033-3044
Author(s):
Michael Stefanidakis and Erkki Koivunen
Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
511-520
Author(s):
Noriyuki Takai, Tami Ueda, Masakazu Nishida, Kaei Nasu and Isao Miyakawa
Combining Gene Therapy and Radiation Against Cancer
Journal:
Current Gene Therapy
Volume:
4
Page:
231-248
Author(s):
Daila S. Gridley and James M. Slater
Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Journal:
Current Gene Therapy
Volume:
4
Page:
297-308
Author(s):
S. Indraccolo
Monoclonal Antibody-based Genetic Immunotherapy
Journal:
Current Gene Therapy
Volume:
4
Page:
347-356
Author(s):
Mireia Pelegrin, Laurent Gros, Hanna Dreja and Marc Piechaczyk
Pharmacogenomics of Arylamine N-acetyltransferase
Journal:
Current Pharmacogenomics
Volume:
2
Page:
219-231
Author(s):
Adeel Mushtaq, Matthew Anderton and Valerie Cornish
Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Journal:
Current Pharmacogenomics
Volume:
2
Page:
243-254
Author(s):
Diane Downie, Patrick H. Rooney, Morag C.E. McFadyen and Graeme I. Murray
Human Reduced Folate Carrier Gene and Transcript Variants: Functional, Physiologic, and Pharmacologic Consequences
Journal:
Current Pharmacogenomics
Volume:
2
Page:
287-298
Author(s):
Larry H. Matherly